Загрузка...
Five-Year Survival Among Stage IIIA Lung Cancer Patients Receiving Two Different Treatment Modalities
BACKGROUND: Five-year survival rates among stage IIIA lung cancer patients range between 2% and 15%, and there is currently no consensus regarding optimal treatment approaches for these patients. The current investigation evaluated survival outcomes among stage IIIA lung cancer patients receiving 2...
Сохранить в:
| Опубликовано в: : | Med Sci Monit |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
International Scientific Literature, Inc.
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5017688/ https://ncbi.nlm.nih.gov/pubmed/27442604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.898675 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|